Dr. Lycan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Wake Forest Medical Center
Winston Salem, NC 27157Phone+1 336-716-2011
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2012 - 2015
Rowan University School of Osteopathic MedicineClass of 2012
Certifications & Licensure
NC State License 2012 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy Start of enrollment: 2020 Jul 01
Publications & Presentations
PubMed
- Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.Margaret R Smith, Caroline B Dixon, Yuezhu Wang, Yin Liu, Ralph D'Agostino Jr
Cancer Research. 2024-12-02 - Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies.Margaret R Smith, Yuezhu Wang, Caroline B Dixon, Ralph D'Agostino, Yin Liu
Clinical Lung Cancer. 2024-12-01 - IASLC grading system predicts distant metastases for resected lung adenocarcinoma.Yuezhu Wang, Margaret R Smith, Caroline B Dixon, Ralph D'Agostino, Yin Liu
Journal of Clinical Pathology. 2024-08-21
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
